Endoscopic Submucosal Dissection Market

Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) & Region - Global Forecast to 2027

Report Code: MD 8538 Jan, 2023, by marketsandmarkets.com

Endoscopic Submucosal Dissection Market Size, Global Industry Forecast

The global endoscopic submucosal dissection market in terms of revenue was estimated to be worth $347 million in 2022 and is poised to reach $483 million by 2027, growing at a CAGR of 6.9% from 2022 to 2027. The rising incidence of target diseases such as cancer is expected to accelerate the need for endoscopic procedures, which, in turn, would propel the growth of this market in the coming years. Owing to the high capital, training, and maintenance costs, endoscopic submucosal dissection procedures are generally expensive. Also, in most Asian countries, there is limited or no reimbursement for ESD procedures from governments are factor expected to restrain the market growth to a certain extent in the coming years.

Endoscopic Submucosal Dissection Market

To know about the assumptions considered for the study, Request for Free Sample Report

Endoscopic Submucosal Dissection Market Dynamics

Drivers: Growing geriatric population

endoscopic submucosal dissection has become a useful minimally invasive treatment for elderly patients with early-stage gastric cancer, as it is less invasive than open surgical procedures and highly advantageous in organ preservation. ESD enables en-bloc resection even of extensive lesions and accurate pathological evaluation. Furthermore, the aging of the population is associated with an increased number of cases in which the selection of minimally invasive surgery is recommended for elderly patients from various perspectives, including post-operative quality of life (QOL) and procedural accidents. Compared to open surgical procedures, ESD is minimally invasive and has thus been established at various institutions as a highly effective endoscopic treatment for elderly patients.

Restraints: High overhead cost of ESD procedures with limited reimbursements

Endoscopic submucosal dissection has become an established procedure for the resection of pre-malignant lesions. Despite its benefits and cost-effectiveness, there are significant challenges in bringing ESD to mainstream practice, given the unpredictability of reimbursement. ESD is an efficient and cost-effective option for GI cancer patients. However, there are a few complications associated with the use of these devices, which result in additional healthcare costs. The average payment per procedure is USD 886.43 for esophageal ESD, USD 732.71 for gastric or duodenal ESD, and USD 1,325.35 for colon and/or rectal ESD. ESD is consistently under-reimbursed across insurance types when compared to surgical alternatives and endoscopist time. Despite the benefits associated with ESD, the adoption of the technique in the US is hampered by the lengthy learning curve and the lack of dedicated CPT codes after mastering the procedure.

Opportunities: Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries

Endoscopic submucosal dissection was developed in Japan as a novel technique that allowed en bloc removal of early gastric neoplasia regardless of size. Subsequently, its indications expanded to superficial neoplasia in the esophagus and colon. ESD allows for the en bloc removal of neoplasia when en bloc EMR is not possible due to the size or invasion depth of the lesion. Currently, Japanese, American, and European societies provide guidelines for the indications of ESD. ESD is well-established as a modality for selected advanced lesions of both the upper and lower gastrointestinal tract but has not attained the same niche in developing countries due to a variety of reasons. These include competition from traditional surgery, minimally invasive surgery, and EMR. Other obstacles to ESD introduction include time commitment for learning and performing procedures, a steep learning curve, requirement of special equipment, lack of mentors, cost issues, interdisciplinary conflicts, concerns regarding complications, and lack of support from institutions and interfacing departments. One of the largest barriers to the adoption of ESD is that the operative time of ESD will remain longer than most endoscopic procedures (given the inherent nature of ESD). However, a decrease in procedural time is expected owing to technological advancements. This, in turn, is expected to increase the adoption and preference for endoscopic submucosal dissection procedures in developing countries during the forecast period.

Challenges: Risk of post-operative infection

Endoscopic submucosal dissection is a relatively new procedure used for the treatment of early gastrointestinal cancers, regardless of lesion size and configuration. It has gradually acquired popularity because of its minimally invasive nature. As compared to conventional endoscopic resection, ESD is a more complex procedure and requires a higher level of technical skill. Therefore, it is associated with a higher complication rate. Post-operative fever is one of the common complications. During ESD, the injection needle catheter is passed through the contaminated endoscopic channel and may directly inoculate bacteria into the bloodstream during the submucosal injection. In addition, ESD can produce mucosal defects. Submucosal and muscularis propria being exposed to native bacterial flora in the gastrointestinal tract may lead to bacteremia and/or endotoxemia. Bacteremia could be caused by the bacterial translocation of endogenous microbial flora through the injured mucosa into the bloodstream during the endoscopy procedure. These infectious complications have been reported to be infrequent and transient in both EMR and ESD of the stomach and colon.

Based on product, the knives segment will grow at the highest CAGR during the forecast period

Based on product, the endoscopic submucosal dissection market is segmented into knives, tissue retractors, graspers/clips, injection agents, gastroscopes and colonoscopes, and other products. The knives segment will continue to dominate the market in 2027, growing at the highest CAGR during the forecast period. In ESD, lesions are circumscribed with a knife to free the lesion completely from the rest of the normal mucosa. There are a variety of knives available in the market, and the field has evolved rapidly over the past two decades with efforts to improve efficacy, safety, and cost-effectiveness.

Based on indication, the esophageal cancer segment will grow at the highest CAGR during the forecast period

Based on indication, the endoscopic submucosal dissection market is segmented into stomach cancer, colon cancer, and esophageal cancer. The esophageal cancer segment will grow at the highest CAGR during the forecast period. The incidence of superficial esophageal cancer (SEC) is increasing, particularly in Asian countries, including Japan, where screening for upper digestive tract cancers is common.

Based on end user, the hospitals segment will grow at the highest CAGR during the forecast period

In 2021, the hospitals segment will grow at the highest CAGR during the forecast period. Investments and incentives received by hospitals from government bodies are few key factors for the growth of this segment.

North America is expected to account for the largest share of the endoscopic submucosal dissection market in 2021

Endoscopic Submucosal Dissection Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America is expected to account for the largest share of the endoscopic submucosal dissection market in 2021. Its dominance in the global market is mainly attributed to the high healthcare spending in the country, favorable reimbursement policies for endoscopic procedures, increased incidence of cancer, constant research on endoscopy techniques, and a high number of FDA approvals for endoscopy systems in the US.

The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Holdings Corporation (Japan), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical (UK), Medtronic (Ireland), MTW Endoskopie Manufaktur (Germany), HOYA Corporation (Japan), Ovesco Endoscope AG (Germany), Zeon Medical Inc. (Japan), KARL STORZ SE & Co. KG (Germany), ConMed Corporation (US), Micro-tech Endoscopy (China), Cook Group (US), Steris PLC (Ireland), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical (South Korea), DCC Healthcare (Ireland), Kossen Co., Ltd. (South Korea), Innova Medica SPA (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS MedTech Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).

Endoscopic Submucosal Dissection Market Report Scope

Report Metric

Details

Market Revenue in 2022

$347 million

Estimated Value by 2027

$483 million

Growth Rate

poised to grow at a CAGR of 6.9%

Largest Market

North America

Market Report Segmentation

Product, Indication, End User & Region

Growth Drivers

  • Increasing use of endoscopy in detection and treatment procedures
  • Rising prevalence of cancer
  • Growing geriatric population

Growth Opportunities

  • Growing demand for minimally invasive procedures
  • Growing investments in research and development of endoscopy technology
  • Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries

Geographies covered

North America, Europe, APAC, MEA, and Latin America

Endoscopic Submucosal Dissection Market Report Segmentation

By Product

  • Gastroscopes And Colonoscopes
  • Knives
  • Injection Agents
  • Tissue Retractors
  • Graspers/Clips
  • Other Products

By Indication

  • Stomach Cancer
  • Colon Cancer
  • Esophageal Cancer

By End User

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Endoscopic Submucosal Dissection Market
Recent Developments

  • In March 2021, FUJIFILM Holdings Corporation (Japan) acquired Diagnostic Imaging-related Business (the Business), Hitachi, Ltd.. This acquisition helped in the expansion of the medical systems business of FUJIFILM Corporation.
  • In January 2021, Olympus Corporation (Japan) acquired Quest Innovations B.V. (Netherlands). The acquisition enabled Olympus to strengthen its surgical endoscopy capabilities and incorporate Quest’s advanced FIS capabilities into its comprehensive medical imaging portfolio.
  • In November 2020, Creo Medical Group PLC (UK) acquired Boucart Medical SRL (Belgium). Creo Medical Group completed the acquisition of Boucart Medical SRL, the largest independent supplier of gastrointestinal endoscopy consumables in Belgium and Luxembourg.

Frequently Asked Questions (FAQs):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 26)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
          TABLE 1 STANDARD CURRENCY CONVERSION RATES
    1.6 SCOPE-RELATED LIMITATIONS 
    1.7 STAKEHOLDERS 
 
2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
          FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021)
          FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
          FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 12 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 13 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION 
    2.5 STUDY ASSUMPTIONS 
    2.6 METHODOLOGY-RELATED LIMITATIONS 
    2.7 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
 
3 EXECUTIVE SUMMARY (Page No. - 45)
    FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
 
4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW 
          FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY 
          FIGURE 19 GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
    4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX 
          FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX 
          FIGURE 21 NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD
    4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS 
          FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing use of endoscopy in detection and treatment procedures
                    5.2.1.2 Rising prevalence of cancer
                                FIGURE 24 GLOBAL CANCER INCIDENCE, 2008–2030
                    5.2.1.3 Growing geriatric population
                                FIGURE 25 SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030)
                                TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040
           5.2.2 RESTRAINTS
                    5.2.2.1 Dearth of skilled professionals
                    5.2.2.2 High overhead cost of ESD procedures with limited reimbursements
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for minimally invasive procedures
                    5.2.3.2 Growing investments in research and development of endoscopy technology
                                TABLE 4 MAJOR DEVELOPMENTS
                    5.2.3.3 Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries
           5.2.4 CHALLENGES
                    5.2.4.1 Higher rate of complications
                    5.2.4.2 Risk of post-operative infection
    5.3 INDUSTRY TRENDS 
           5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
           5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION
    5.4 REGULATORY ANALYSIS 
           5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.4.2 NORTH AMERICA
                    5.4.2.1 US
                    5.4.2.2 Canada
           5.4.3 EUROPE
                    5.4.3.1 Germany
                    5.4.3.2 France
                    5.4.3.3 UK
                    5.4.3.4 Italy
    5.5 ECOSYSTEM MARKET MAP 
          FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP
    5.6 VALUE CHAIN ANALYSIS 
          FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
                    5.7.1.1 High capital requirement
                    5.7.1.2 High preference for products from well-established brands
           5.7.2 THREAT OF SUBSTITUTES
                    5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection
           5.7.3 BARGAINING POWER OF SUPPLIERS
                    5.7.3.1 Presence of several raw material suppliers
                    5.7.3.2 Supplier switching cost
           5.7.4 BARGAINING POWER OF BUYERS
                    5.7.4.1 Limited number of companies offering premium products at global level
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
                    5.7.5.1 Increasing demand for high-quality and innovative products
                    5.7.5.2 Lucrative growth potential in emerging markets
    5.8 INDICATIVE PRICING MODEL ANALYSIS 
          TABLE 9 AVERAGE SELLING PRICE, BY PRODUCT (USD)
    5.9 PATENT ANALYSIS 
           5.9.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
                    FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022
           5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS
                    FIGURE 29 TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–2022
           5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
                    FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022
    5.10 SUPPLY CHAIN ANALYSIS 
          FIGURE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN
    5.11 KEY CONFERENCES AND EVENTS DURING 2022–2023 
           TABLE 10 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
                     TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
           5.12.2 BUYING CRITERIA
                     FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
                     TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
 
6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT (Page No. - 77)
    6.1 INTRODUCTION 
          TABLE 13 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 GASTROSCOPES AND COLONOSCOPES 
           6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH
                    TABLE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 KNIVES 
           6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH
                    TABLE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 INJECTION AGENTS 
           6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH
                    TABLE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 TISSUE RETRACTORS 
           6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS
                    TABLE 17 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 GRASPERS/CLIPS 
           6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND
                    TABLE 18 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.7 OTHER PRODUCTS 
          TABLE 19 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION (Page No. - 85)
    7.1 INTRODUCTION 
          TABLE 20 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
          TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES)
    7.2 STOMACH CANCER 
           7.2.1 STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS
                    TABLE 22 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040)
                    TABLE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 24 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
    7.3 COLON CANCER 
           7.3.1 COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE
                    TABLE 25 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040)
                    TABLE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
    7.4 ESOPHAGEAL CANCER 
           7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE
                    TABLE 28 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040)
                    TABLE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
 
8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER (Page No. - 93)
    8.1 INTRODUCTION 
          TABLE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.2 HOSPITALS 
           8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH
                    TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 SPECIALTY CLINICS 
           8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH
                    TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 AMBULATORY SURGICAL CENTERS 
           8.4.1 GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS
                    TABLE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.5 OTHER END USERS 
          TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
 
9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION (Page No. - 100)
    9.1 INTRODUCTION 
          FIGURE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 35 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
          TABLE 37 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 38 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 39 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
          TABLE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US is largest market for endoscopic submucosal dissection products
                                TABLE 41 US: MACROECONOMIC INDICATORS
                                TABLE 42 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 43 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 44 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Slower healthcare development in Canada over past decade to restrain growth
                                TABLE 45 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040
                                TABLE 46 CANADA: MACROECONOMIC INDICATORS
                                TABLE 47 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 48 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 49 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.3 EUROPE 
          TABLE 50 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 51 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 52 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
          TABLE 53 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Germany to account for largest share of European market
                                TABLE 54 GERMANY: MACROECONOMIC INDICATORS
                                TABLE 55 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 56 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 57 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.2 FRANCE
                    9.3.2.1 High-quality healthcare system offering coverage to all citizens to support market growth
                                TABLE 58 FRANCE: MACROECONOMIC INDICATORS
                                TABLE 59 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 60 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 61 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.3 UK
                    9.3.3.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market
                                TABLE 62 UK: MACROECONOMIC INDICATORS
                                TABLE 63 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 64 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 65 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth
                                TABLE 66 ITALY: MACROECONOMIC INDICATORS
                                TABLE 67 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 68 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 69 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Rising prevalence of cancer to drive market growth
                                TABLE 70 SPAIN: MACROECONOMIC INDICATORS
                                TABLE 71 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 72 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 73 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 74 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 75 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                    TABLE 76 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC 
          FIGURE 36 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
          TABLE 77 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 78 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 79 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
          TABLE 80 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Supportive medical device reimbursement policies to drive market growth
                                TABLE 81 JAPAN: MACROECONOMIC INDICATORS
                                TABLE 82 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 83 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 84 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth
                                TABLE 85 CHINA: MACROECONOMIC INDICATORS
                                TABLE 86 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 87 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 88 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth
                                TABLE 89 INDIA: MACROECONOMIC INDICATORS
                                TABLE 90 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 91 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                                TABLE 92 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 93 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 94 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                    TABLE 95 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH
                    TABLE 96 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 97 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                    TABLE 98 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA 
           9.6.1 HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES
                    TABLE 99 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 100 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION)
                    TABLE 101 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 138)
     10.1 INTRODUCTION 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
     10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS 
            FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
     10.4 MARKET SHARE ANALYSIS 
            FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021)
     10.5 COMPANY FOOTPRINT ANALYSIS 
             10.5.1 FOOTPRINT OF COMPANIES, BY PRODUCT
             10.5.2 FOOTPRINT OF COMPANIES, BY END USER
             10.5.3 FOOTPRINT OF COMPANIES, BY REGION
     10.6 COMPANY EVALUATION MATRIX 
             10.6.1 STARS
             10.6.2 EMERGING LEADERS
             10.6.3 PERVASIVE PLAYERS
             10.6.4 PARTICIPANTS
                        FIGURE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX
     10.7 COMPETITIVE BENCHMARKING 
             TABLE 102 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES
     10.8 COMPETITIVE SCENARIO 
             10.8.1 PRODUCT LAUNCHES
                        TABLE 103 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022)
             10.8.2 DEALS
                        TABLE 104 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022)
             10.8.3 OTHER DEVELOPMENTS
                        TABLE 105 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022)
 
11 COMPANY PROFILES (Page No. - 150)
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
     11.1 KEY PLAYERS 
             11.1.1 OLYMPUS CORPORATION
                        TABLE 106 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022)
             11.1.2 FUJIFILM HOLDINGS CORPORATION
                        TABLE 107 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 41 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021)
             11.1.3 BOSTON SCIENTIFIC CORPORATION
                        TABLE 108 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
                        FIGURE 42 COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021)
             11.1.4 MEDTRONIC
                        TABLE 109 MEDTRONIC: BUSINESS OVERVIEW
                        FIGURE 43 COMPANY SNAPSHOT: MEDTRONIC (2022)
             11.1.5 SUMITOMO BAKELITE CO., LTD.
                        TABLE 110 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW
                        FIGURE 44 COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021)
             11.1.6 CREO MEDICAL GROUP PLC
                        TABLE 111 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW
                        FIGURE 45 COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021)
             11.1.7 HOYA CORPORATION
                        TABLE 112 HOYA CORPORATION: BUSINESS OVERVIEW
                        FIGURE 46 COMPANY SNAPSHOT: HOYA CORPORATION (2022)
             11.1.8 CONMED CORPORATION
                        TABLE 113 CONMED CORPORATION: BUSINESS OVERVIEW
                        FIGURE 47 COMPANY SNAPSHOT: CONMED CORPORATION (2021)
             11.1.9 STERIS PLC
                        TABLE 114 STERIS PLC: BUSINESS OVERVIEW
                        FIGURE 48 COMPANY SNAPSHOT: STERIS PLC (2022)
             11.1.10 MTW ENDOSKOPIE MANUFAKTUR
                        TABLE 115 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS 
             11.2.1 OVESCO ENDOSCOPY AG
                        TABLE 116 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
             11.2.2 ZEON MEDICAL INC.
                        TABLE 117 ZEON MEDICAL INC.: BUSINESS OVERVIEW
             11.2.3 MICRO-TECH ENDOSCOPY
                        TABLE 118 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW
             11.2.4 KARL STORZ SE & CO. KG
                        TABLE 119 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW
             11.2.5 COOK MEDICAL
                        TABLE 120 COOK MEDICAL: BUSINESS OVERVIEW
             11.2.6 LEO MEDICAL CO., LTD.
                        TABLE 121 LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW
             11.2.7 ERBE ELEKTROMEDIZIN GMBH
                        TABLE 122 ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW
             11.2.8 TAEWOONG MEDICAL CO., LTD.
                        TABLE 123 TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW
             11.2.9 DCC HEALTHCARE LIMITED
                        TABLE 124 DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW
             11.2.10 KOSSEN CO., LTD.
                        TABLE 125 KOSSEN CO., LTD.: BUSINESS OVERVIEW
             11.2.11 INNOVAMEDICA S.P.A.
                        TABLE 126 INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW
             11.2.12 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
                        TABLE 127 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
             11.2.13 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
                        TABLE 128 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW
             11.2.14 BEIJING ZKSK TECHNOLOGY CO., LTD.
                        TABLE 129 BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
 
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 194)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the endoscopic submucosal dissection market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side and demand side are detailed below.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Interviews: Supply-Side Participants- by Company Type, Designation, and Region

Endoscopic Submucosal Dissection Market Size, and Share

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Breakdown of Primary Interviews: Demand-Side Participants by End-User, Designation, and Region

 

Endoscopic Submucosal Dissection Market Size, and Share

Note: Others include department heads, research scientists, and professors.

Market Size Estimation

The total size of the endoscopic submucosal dissection market was arrived at after data triangulation from three different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Objectives of the Study

  • To describe, analyze, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
  • To describe and forecast the endoscopic submucosal dissection market for key regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the endoscopic submucosal dissection market
  • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies in the endoscopic submucosal dissection market
  • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the endoscopic submucosal dissection market

Available customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the RoE endoscopic submucosal dissection market into Austria, Finland, and others
  • Further breakdown of the Latin America endoscopic submucosal dissection market into Brazil, Mexico, Argentina, Colombia, Chile, and others

Competitive Landscape Assessment

Market share analysis for the North America and Europe region, which provides market shares of the top 3–5 key players in the endoscopic submucosal dissection market

  • Competitive leadership mapping for established players in the US
Report Code
MD 8538
Published ON
Jan, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Endoscopic Submucosal Dissection Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback